Japan · Delayed Price · Currency is JPY ASKA Pharmaceutical Holdings Company Description
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.
The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials.
It is also involved in the clinical examination and biological testing activities; engages in the manufacturing, sales, import, and distribution of prescription drugs, over-the-counter drugs, health foods, and other products; and offers quasi-drugs, food supplements, and medical devices.
The company was founded in 1920 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1920 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,611 |
| CEO | Sohta Yamaguchi |
Contact Details
Address: 5-1, Shibaura 2-Chome Tokyo, 108-8532 Japan | |
| Phone | 81 3 5484 8845 |
| Website | aska-pharma-hd.co.jp |
Stock Details
| Ticker Symbol | 4886 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3119660003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sohta Yamaguchi | Chief Executive Officer |
| Tomoyuki Hatakeyama | Chief Financial Officer |